Literature DB >> 36267198

Corrigendum.

.   

Abstract

[This corrects the article DOI: 10.1002/bco2.117.].
© 2022 The Authors. BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU International Company.

Entities:  

Year:  2022        PMID： 36267198      PMCID： PMC9579889          DOI： 10.1002/bco2.150

Source DB:  PubMed          Journal:  BJUI Compass        ISSN： 2688-4526


  1 in total

1.  Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer.

Authors:  Yuki Miura; Shingo Hatakeyama; Toshikazu Tanaka; Naoki Fujita; Hirotaka Horiguchi; Yoshiharu Okuyama; Yuta Kojima; Daisuke Noro; Noriko Tokui; Teppei Okamoto; Hayato Yamamoto; Hiroyuki Ito; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  BJUI Compass       Date:  2021-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.